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Background 
Clinical Uses 
Metabolic gas exchange monitors are 
frequently used in the intensive care unit to 
study the oxygen kinetics and appraise the 
nutritional requirements for acutely ill 
patients. In a method known as indirect 
calorimetry, energy expenditure information 
is obtained non-invasively by measuring the 
respiratory gases under resting conditions.
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A modified Weir equation relates the 
oxygen consumption (VO2) and the carbon 
dioxide production (VCO2) to the caloric 
burn rate.
4
 The resting energy expenditure 
(REE) represents approximately 70% of the 
total energy expenditure (TEE).
5
     
Critical illness has been shown to 
alter metabolic rate and influence VO2.  
Inflammation, sepsis, seizures, and weaning 
from ventilation increase the VO2, while 
sedation, muscle paralysis, shock, and 
hypothermia decrease the VO2.  Since 
underfeeding a patient may increase 
catabolism and overfeeding is associated 
with hyperglycemia, increased ventilation 
requirements, and lipogenesis, it is 
imperative for the patient’s recovery that the 
diet meets nutritional requirements.
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Application to Space 
 Orr et al (1989) described the need 
for a small, lightweight, and reliable 
instrument to measure VO2 and VCO2 
aboard the Space Station. This would allow 
astronauts to monitor deconditioning 
associated with weightlessness and track the 
effectiveness of exercise countermeasures.
9
   
 
 
 
Traditional method –Datex Deltatrac 
In clinical practice, the Datex 
Deltatrac Metabolic Monitor (Datex-
Instrumentarium, Helsinki, Finland) is a 
widely-accepted noninvasive metabolic 
monitor useful in determining the indirect 
calorimetry measurements.
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 A 
paramagnetic oxygen sensor is used to 
measure oxygen concentrations; carbon 
dioxide is analyzed using an infrared sensor. 
Gases are collected in a mixing chamber and 
then sampled at a fixed flow rate.   After a 
stabilization period, the data is updated 
every minute. 
However, factors such as the 
bulkiness of the gas mixing chamber, 
incompatibility with other instruments that 
provide physiological information, elapsed 
time required for the Deltatrac to reach a 
steady state, complicated interface, off-site 
equipment repairs, and the requirement of a 
skilled technician to analyze the results deter 
some from using the Deltatrac.
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Novel Approach - NICO2 Metabolic Monitor 
For the reasons cited, Respironics 
developed the NICO2 Cardiopulmonary 
Management System (Respironics, Inc., 
Wallingford CT).  The NICO2 is a compact 
metabolic device with a user friendly 
interface.  In addition to standard flow and 
CO 2 sensors, a novel on-airway oxygen 
sensor using luminescence quenching 
technology has been developed to determine 
oxygen consumption.  The benefits of this 
sensor are the real-time oxygen consumption 
analysis and the elimination of water 
condensation collecting in the hoses of the 
drawn sample.
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 The oxygen sensor portion of the 
instrument consists of a light emitting diode 
which serves as the excitation source. A 
photosensitive detector is mounted in a 
position to respond to the filtered fluorescent 
radiation emerging from the exit optical 
filter. The oxygen sensor is comprised of a 
thin film of transparent material containing 
luminescent dye in which rapid diffusion of 
molecular oxygen from the airway gas 
environment takes place. Oxygen 
concentration is proportional to the amount 
of quenching observed when in the 
fluorescence, Figure 1.
 
This oxygen signal 
is presently designed to give a simple 
oxygen waveform and measurement of 
inspired and expired oxygen with the 
existing flow signal to calculate oxygen 
uptake in resting patients.  Bench 
simulations found that the new device 
measure oxygen consumption with an 
average difference of 0.3+-2.8% at inspired 
oxygen levels between 30%-50%.
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Figure 1 Schematic of luminescence quenching (a) 
when no oxygen is present the dye fluoresces; (b) 
oxygen molecules quench the fluorescence  
 Using the Deltatrac as a standard, the 
accuracy and precision of luminescence 
quenching oxygen sensor were evaluated in 
healthy volunteers.   
Methods 
Subjects 
Twenty healthy volunteers between 
the ages of 18-60 were recruited to 
participate.  Weight and height were 
measured on a Health O Meter Professional 
dial scale. Height of the volunteers was 
measured to the nearest inch.  The 
characteristics of the volunteer group are 
presented in Table 1.   
 
Table 1  Patient characteristics 
Gender  10 F 10 M 
Age (yr) 30±12.1 27.5±7.7 
Weight (lbs) 145.2±-25.9 179±40.5 
Height (inches) 66.9±2.1 72.2±1.4 
M=male; F=female   
Data presented as mean ± s.d  
 
Design Protocol  
Subjects were seated in a chair and 
instructed not to speak, minimize 
movements during the experiment, and 
breathe normally through a disposable 
mouthpiece to which the O2, CO2 and flow 
sensors were attached. A disposable nose 
clip was used to prevent breathing or leaking 
of gases through the nose.   
The distal side of the sensor was 
connected to a valved T-piece such that all 
expired gas was diverted through a hose to 
the reference oxygen uptake analyzer. The 
one-way valves on the T-piece were 
replaced after each subject to prevent wear 
on the valve.  Two mixing bags were 
connected to ensure homogeneous mixing of 
the inspired gas and to prevent forced 
airflow through the hose and across the 
sensor, Figure 2. The on airway oxygen 
sensor is labeled.   Figure 3 depicts the 
bulkiness of the Deltatrac mixing chambers.     
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Figure 2 Volunteer study set-up 
 
 
 
 
Measurement of Oxygen Consumption 
Oxygen consumption was measured 
simultaneously using a Deltatrac II 
metabolic monitor and by the NICO2 
Cardiopulmonary Management System. 
Each morning, prior to use, the system was 
allowed a warm up period of 30 minutes, as 
recommended by the manufacturer.  Prior to 
use, the system sensors were calibrated at 
two gas concentrations of 20% oxygen, 5% 
carbon dioxide balance nitrogen (Scott 
Medical Products, Plumsteadville, PA) and 
with 100% oxygen. 
The systems were given a 10 minute 
stabilization period for each subject, and 
then VO2 and VCO2 from the Deltatrac and 
NICO2 systems were recorded at 1 minute 
intervals and continuously, respectively.   
Breath data was collected for about 15 
minutes.  Following the first data collection 
of air, subjects were allowed to rest, and 
then the process was repeated with inspired 
gas of 40% oxygen and balance nitrogen.   
The resting metabolic rate (RMR) 
was calculated using the abbreviated Weir 
equation:  
RMR = [(3.941 * VO2) + (1.106 * 
VCO2)]*1.440 
 
where VO2 and VCO2 are measured in liters 
per day (ml/min) and RMR in kilocalories  
per day (Kcal).   
 
Metabolic measurements are determined by 
integrating the product of the flow and 
oxygen signals over the entire breath.   
 
Statistical analysis 
Reproducibility and agreement 
between the Deltatrac and NICO2 RMR 
were assessed as outlined by the Bland-
Altman limits of agreement testing.  All 
statistical analyses were performed using 
Excel 2002 for Windows.   
 
Results 
Data was collected from 20 healthy 
volunteers using the Deltatrac system and 
NICO2 system.  Although some volunteers 
expressed discomfort, no-one was unable to 
complete the study.  Previous studies have 
shown the canopy gas collection method to 
be preferred over the mouthpiece.  One 
volunteer had a moderate gas leak around 
the mouthpiece, which was quickly 
corrected.  A few volunteers appeared to be 
On-airway oxygen sensor 
 
Figure 3  A size comparison of the NICO2 (top) and 
Deltatrac (bottom) metabolic monitors 
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restless. All volunteer data was included in 
the statistical analysis.   
The difference between VO2 
measured by the Deltatrac and NICO2 had a 
mean and standard deviation of -5.5 ±10.2 (-
2.09 ±3.86%) and 5.1 ±18.1 (1.77 ±6.29%) 
ml/min for 21% and 40% oxygen, 
respectively (Table 2). The NICO2 
measurements were lower than the Deltatrac 
at oxygen levels of 21%, but NICO2 
measurements were higher at 40% oxygen.  
 
Table 2  Measurement differences for NICO2™ vs. 
Deltatrac™(n=20), O2 Consumption (VO2), CO2 
production (VCO2), and RQ mean and s.d. 
Mean 
Difference*     
 21% Oxygen 40% Oxygen 
VO2 (ml/min) -5.5 ±10.2 5.1 ±18.1 
VCO2 (ml/min) 3.9±10.4 4.6±10.5 
RQ -0.1±0.08 -0.1±0.07 
REE (kcal/day) -25±74.4 36.27±119.4 
Percent Difference** 
 21% Oxygen 40% Oxygen 
VO2  -2.09 ±3.86% 1.77 ±6.29% 
VCO2  1.63±4.41% 2.05±4.69% 
RQ -11.44±9.31% -15.21±8.66% 
*Data presented as mean ± s.d. 
**Data presented as mean % diff ± % s.d. 
 
A linear comparison of the VO2 for 
the Deltatrac and NICO2 is shown in Figure 
4.The correlation coefficients for as shown: 
for r
2
= 0.9735 for 21% oxygen, and r
2 
= 
0.9164 for 40% oxygen.    
Figure 5 and Figure 6 shows Bland-
Altman difference and limits of agreement 
for VO2.
16
  Two standard deviations are 
shown by the dotted green line.   
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Figure 4  Linear X-Y the plot of NICO2 vs. 
Deltatrac at 21% and 40% oxygen 
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Figure 5 Bland-Altman difference -5.9 ± 10.4 
ml/min (-2.2 ±4.4%) and the limits of agreement 
at 21% FiO2 
VO2 Results, FiO2:40% Oxygen
-60
-40
-20
0
20
40
60
0 100 200 300 400
Mean Deltatrac & On-Airway VO2 (ml/min)
O
n
 A
ir
w
a
y
 -
  
D
e
lt
a
tr
a
c
 V
O
2
 (
m
l/
m
in
)
 
Figure 6 Bland-Altman difference 5.1 ± 18.1 
ml/min (1.8 ± 6.3%) and the limits of agreement at 
40% FiO2 
 
Discussion 
The main aim of this study was to 
assess the validity of the new NICO2 
luminescent quenching oxygen sensor by 
comparing it to the clinical “gold standard” 
the Datex Deltatrac.
17
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On average the oxygen consumption 
measured by the NICO2 was less than 5% 
higher than that measured by the Deltatrac at 
21% oxygen.  This difference was shown to 
be dependent on the oxygen level.  Validity 
tests on the Med Gem, a handheld metabolic 
monitor, reported a 10% higher oxygen 
consumption reading over the Deltatrac. The 
Med Gem showed no significant differences 
in the measurement of VO2 and RMR in 
healthy subjects.  In the validation, Neieman 
et al (2003) evaluated a Body Gem 
metabolic monitor against the Douglas bag 
technique and found the correlation 
coefficients for oxygen consumption ranged 
0.81 to 0.87.
13, 18
  In our study of the NICO2 
and the Deltatrac, correlations ranged from 
0.9164 to 0.9735.   
  The M-COVX, another compact and 
compatible metabolic monitor, measures 
VO2 and VCO2 on a breath to breath basis, 
similar to the NICO2.  Furthermore, it also 
uses a mathematical algorithm in order to 
provide data continuously.  When compared 
to the Deltatrac, McLellan et all (2002) 
found that the M-COVX performed better 
than the Deltatrac at high FiO2.
19
 It was 
found to be adequate when measuring 
respiratory gas exchange in ventilated 
critically ill patients.   
Both systems were easily calibrated 
and the data collection was straight forward.  
Although both machines could require off-
site equipment repairs, the compact NICO2 
is more easily transported than the Deltatrac 
cart, which hogs 6.6 squared feet of floor 
space and 3.4 feet vertical space.  This also 
increases accessibility in tight spaces, such 
as the ICU.  The NICO2 oxygen sensor has a 
relatively short lifetime of ~4 days, but it is 
easily detached and replaced.  This lifetime 
is adequate for a typical stay in the ICU.   
This study had several limitations 
that should be considered.  First, our goal 
was to validate the NICO2 oxygen sensor, 
thus repeated measure of the Deltatrac RMR 
was not taken. Previous research has fully 
established this indirect calorimeter to be 
within 5% for repeated measures.
20
  Second, 
stabilization of the Deltatrac at steady state 
did not always occur after the prescribed 
warm up period.  The protocol allowed for 
15 minutes of data collection, a time that 
could be increased, but would cause an 
increased restlessness in the volunteers. 
Third, time and limited funding provided for 
only 20 volunteers.  A larger, more diverse 
sample size would strengthen the study. To 
obtain an accurate RMR measurement by 
indirect calorimetry, factors such as recent 
physical activity, fasting and resting time 
must also be taken into consideration.
21
 
Further research is needed before the NICO2 
could replace the Deltatrac in clinical 
applications.   
 
Conclusions 
Determining an accurate RMR/REE 
is important when assessing the nutritional 
requirements of healthy and sick individuals.  
Clinicians, nutrition specialists, and even 
athletes use this crucial information when 
establishing individual-specific energy 
needs.  This information is especially vital 
when caring for patients who are critically 
ill because overfeeding/underfeeding can 
have diverse affects on a patient’s recovery.  
Indirect calorimetry is a reliable, non-
invasive method for assessing the 
RMR/REE.  The results of this trial reveal 
the on-airway luminescence quenching 
oxygen sensor VO2 measurements were 
replicable and are feasible for use in an ICU 
setting.. 
 
References 
1. Haugen HA, Chan LN, Li F. Indirect calorimetry: 
A practical guide for clinicians. Nutrition in Clinical 
Practice 2007;22:377-88. 
2. da Rocha EEM, Alves VGF, da Fonseca RBV. 
Indirect calorimetry: methodology, instruments and 
clinical application. Current Opinion in Clinical 
Nutrition and Metabolic Care 2006;9:247-56. 
 6 
3. Ferrannini E. THE THEORETICAL BASES OF 
INDIRECT CALORIMETRY - A REVIEW. 
Metabolism-Clinical and Experimental 1988;37:287-
301. 
4. Weir JBdV. New methods for calculating 
metabolic rate with special reference to protein 
metabolism. J Physiol 1949;109:1-9. 
5. Feurer IM, J.L. Bedside measurement of resting 
energy expenditure and respiratory quotient via 
indirect calorimetry  Nutrition in Clinical Practice 
1986;1:43-9. 
6. Battezzati A, Vigano R. Indirect calorimetry and 
nutritional problems in clinical practice. Acta 
Diabetologica 2001;38:1-5. 
7. Walsh TS. Recent advances in gas exchange 
measurement in intensive care patients. British 
Journal of Anaesthesia 2003;91:120-31. 
8. Basile A, Martins MA, Marson F, Evora PRB. An 
easy way to estimate energy expenditure from 
hemodynamic data in septic patients. Acta Cirurgica 
Brasileira 2008;23:112-7. 
9. Orr JA, Westenskow DR, Bauer A. A 
PROTOTYPE GAS EXCHANGE MONITOR FOR 
EXERCISE STRESS TESTING ABOARD NASA 
SPACE STATION. Journal of Applied Physiology 
1989;66:492-7. 
10. Alam DS, Hulshof PJM, Roordink D, et al. 
Validity and reproducibility of resting metabolic rate 
measurements in rural Bangladeshi women: 
comparison of measurements obtained by Medgem 
(TM) and by Deltatrac (TM) device. European 
Journal of Clinical Nutrition 2005;59:651-7. 
11. Tissot S, Delafosse B, Bertrand O, Bouffard Y, 
Viale JP, Annat G. Clinical validation of the 
Deltatrac monitoring system in mechanically 
ventilated patients. Intensive Care Medicine 
1995;21:149-53. 
12. Weissman C, Sardar A, Kemper M. INVITRO 
EVALUATION OF A COMPACT METABOLIC 
MEASUREMENT INSTRUMENT. Journal of 
Parenteral and Enteral Nutrition 1990;14:216-21. 
13. Nieman DC, Trone GY, Austin MD. A new 
handheld device for measuring resting metabolic rate 
and oxygen consumption. Journal of the American 
Dietetic Association 2003;103:588-93. 
14. Khalil G-E, Gouterman, Martin P., Green, 
Edmond, inventor Method and sensor for measuring 
oxygen concentration patent 5043286. 1991. 
15. Orr J. Indirect Calorimetry System Based on 
Luminescence Quenching On-Airway Oxygen 
Sensor. Anesthesia and Analgesia 2007;105:S112-S3. 
16. Bland JM, Altman DG. STATISTICAL-
METHODS FOR ASSESSING AGREEMENT 
BETWEEN 2 METHODS OF CLINICAL 
MEASUREMENT. Lancet 1986;1:307-10. 
17. Holdy KE. Monitoring Energy Metabolism with 
Indirect Calorimetry: Instruments, Interpretation, and 
Clinical Application. Nutr Clin Pract 2004;19:447-
54. 
18. Compher C, Hise M, Sternberg A, Kinosian BP. 
Comparison between Medgem and Deltatrac resting 
metabolic rate measurements. European Journal of 
Clinical Nutrition 2005;59:1136-41. 
19. McLellan S, Walsh T, Burdess A, Lee A. 
Comparison between the Datex-Ohmeda M-COVX 
metabolic monitor and the Deltatrac II in 
mechanically ventilated patients. Intensive Care 
Medicine 2002;28:870-6. 
20. Shetty PS, Henry CJK, Black AE, Prentice AM. 
Energy requirements of adults: An update on basal 
metabolic rates (BMRs) and physical activity levels 
(PALs). European Journal of Clinical Nutrition 
1996;50:S11-S23. 
21. Brooks GA, Butte NF, Rand WM, Flatt JP, 
Caballero B. Chronicle of the Institute of Medicine 
physical activity recommendation: how a physical 
activity recommendation came to be among dietary 
recommendations. American Journal of Clinical 
Nutrition 2004;79:921-30. 
 
 
